We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+16.88%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.03B
AUM Growth
-$287M
Cap. Flow
-$398M
Cap. Flow %
-38.68%
Top 10 Hldgs %
14.04%
Holding
1,478
New
335
Increased
269
Reduced
346
Closed
503

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Consumer Discretionary 12.74%
3 Healthcare 12.34%
4 Communication Services 10.34%
5 Industrials 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RNW icon
901
ReNew
RNW
$2.25B
$111K 0.01%
16,064
-6,975
-30% -$45.5K
NOK icon
902
Nokia
NOK
$52.3B
$111K 0.01%
+21,373
New +$110K
RLGT icon
903
Radiant Logistics
RLGT
$395M
$111K 0.01%
18,200
+7,800
+75% +$46.7K
QUAD icon
904
Quad
QUAD
$525M
$111K 0.01%
19,584
+300
+2% +$1.63K
ACCO icon
905
Acco Brands
ACCO
$407M
$109K 0.01%
30,400
-12,800
-30% -$47.3K
SEER icon
906
Seer Inc
SEER
$120M
$108K 0.01%
+50,621
New +$101K
PCAPU
907
ProCap Acquisition Corp Unit
PCAPU
$213M
$107K 0.01%
+10,000
New +$111K
BRY
908
DELISTED
Berry Corp
BRY
$107K 0.01%
38,700
-44,600
-54% -$119K
GOGL
909
DELISTED
Golden Ocean Group
GOGL
$107K 0.01%
+14,617
New +$111K
YARW
910
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
$107K 0.01%
1,292
-1,538
-54% -$100K
LFCR icon
911
Lifecore Biomedical
LFCR
$190M
$106K 0.01%
13,096
-10,871
-45% -$73.3K
WENNU
912
Wen Acquisition Corp Unit
WENNU
$106K 0.01%
+10,000
New +$106K
OIS icon
913
Oil States International
OIS
$491M
$106K 0.01%
19,700
+1,000
+5% +$4.42K
CMPOW
914
DELISTED
CompoSecure Inc Warrant
CMPOW
$104K 0.01%
16,560
FIGXU
915
FIGX Capital Acquisition Corp Units
FIGXU
$140M
$103K 0.01%
+10,259
New +$103K
UEIC icon
916
Universal Electronics
UEIC
$61.3M
$102K 0.01%
15,456
-7,865
-34% -$48.1K
PRME icon
917
Prime Medicine
PRME
$559M
$102K 0.01%
+41,288
New +$63.6K
LEG icon
918
Leggett & Platt
LEG
$1.31B
$101K 0.01%
+11,378
New +$98K
BORR
919
Borr Drilling
BORR
$1.19B
$98K 0.01%
53,543
+15,041
+39% +$28.4K
ELDN icon
920
Eledon Pharmaceuticals
ELDN
$285M
$97.9K 0.01%
36,141
-3,230
-8% -$9.69K
RBBN icon
921
Ribbon Communications
RBBN
$383M
$95.2K 0.01%
23,738
-9,980
-30% -$36K
OLMA icon
922
Olema Pharmaceuticals
OLMA
$1.05B
$94.3K 0.01%
+22,133
New +$98.7K
CXDO icon
923
Crexendo
CXDO
$222M
$92.5K 0.01%
15,232
+1,689
+12% +$8.82K
NUS icon
924
Nu Skin
NUS
$267M
$91.9K 0.01%
11,500
-7,600
-40% -$53.4K
CRGX
925
DELISTED
CARGO Therapeutics
CRGX
$91.2K 0.01%
22,141
-15,459
-41% -$66.2K

Similar funds

Prelude Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Prelude Capital Management held 1,478 positions worth $1.03B, down 22% from $1.32B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Prelude Capital Management withdrew a net $398M in Q2 2025, closing 503 positions and reducing 346 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Prelude Capital Management opened a new position in Alphabet (Google) Class C worth $11.7M.

  • Prelude Capital Management's largest Q2 2025 buy was Alphabet (Google) Class C: 65,723 shares worth $11.7M.
  • Prelude Capital Management added most to Meta Platforms (Facebook) in Q2 2025, an estimated $12.3M increase.
  • Prelude Capital Management's biggest Q2 2025 reduction was Broadcom, cutting an estimated $9.33M.
  • Prelude Capital Management fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $10.4M.
  • Prelude Capital Management's ten largest holdings make up 14% of its $1.03B portfolio in Q2 2025.
  • Prelude Capital Management opened 335 new positions and closed 503 in Q2 2025.
  • Prelude Capital Management's portfolio value fell 22% quarter-over-quarter to $1.03B.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.